Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Shteinberg

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
American Journal of Respiratory and Critical Care Medicine|January 25, 2024
The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)Eva Polverino, Anthony De Soyza, Katerina Dimakou, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 24, 2024
Standards for the care of people with cystic fibrosis (CF); Planning for a longer lifeAndrea Gramegna, Charlotte Addy, Lorna Allen, et al.
The Lancet. Respiratory Medicine|September 27, 2021
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendationsStefano Aliberti, Pieter C Goeminne, Anne E O'Donnell, et al.
The European Respiratory Journal|April 12, 2024
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Arietta Spinou, Beatriz Hererro-Cortina, Stefano Aliberti, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2023
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosisKevin W Southern, Carlo Castellani, Elise Lammertyn, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2024
Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)Eva Polverino, Katerina Dimakou, Letizia Traversi, et al.
The Lancet. Respiratory Medicine|April 27, 2026
Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort studyAmelia Shoemark, Emma D Johnson, Morven Shuttleworth, et al.
Thorax|March 23, 2025
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Jennifer Pollock, Eva Polverino, Raja Dhar, et al.
The European Respiratory Journal|April 12, 2024
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Stefano Aliberti, Felix C Ringshausen, Raja Dhar, et al.
The Lancet. Respiratory Medicine|August 30, 2025
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational studyOriol Sibila, Jamie Stobo, Lidia Perea, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
American Journal of Respiratory and Critical Care Medicine|January 25, 2024
The Association between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC)Eva Polverino, Anthony De Soyza, Katerina Dimakou, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 24, 2024
Standards for the care of people with cystic fibrosis (CF); Planning for a longer lifeAndrea Gramegna, Charlotte Addy, Lorna Allen, et al.
The Lancet. Respiratory Medicine|September 27, 2021
Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendationsStefano Aliberti, Pieter C Goeminne, Anne E O'Donnell, et al.
The European Respiratory Journal|April 12, 2024
Airway clearance management in people with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Arietta Spinou, Beatriz Hererro-Cortina, Stefano Aliberti, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 14, 2023
Standards of care for CFTR variant-specific therapy (including modulators) for people with cystic fibrosisKevin W Southern, Carlo Castellani, Elise Lammertyn, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2024
Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)Eva Polverino, Katerina Dimakou, Letizia Traversi, et al.
The Lancet. Respiratory Medicine|April 27, 2026
Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort studyAmelia Shoemark, Emma D Johnson, Morven Shuttleworth, et al.
Thorax|March 23, 2025
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Jennifer Pollock, Eva Polverino, Raja Dhar, et al.
The European Respiratory Journal|April 12, 2024
Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)Stefano Aliberti, Felix C Ringshausen, Raja Dhar, et al.
The Lancet. Respiratory Medicine|August 30, 2025
Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational studyOriol Sibila, Jamie Stobo, Lidia Perea, et al.
Pageof 15